Stratec SE buy melinda
Start price
17.11.17
/
50%
€64.00
Target price
20.11.17
€65.50
Performance (%)
2.73%
End price
20.11.17
€65.75
Summary
This prediction ended on 20.11.17 with a price of €65.75. With a performance of 2.73%, the BUY prediction by melinda for Stratec SE closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Stratec SE | 0.820% | 0.820% | -31.309% | -61.260% |
| iShares Core DAX® | 0.855% | 1.375% | 2.609% | 52.294% |
| iShares Nasdaq 100 | -0.989% | -3.844% | 25.552% | 78.877% |
| iShares Nikkei 225® | -1.781% | -8.530% | 42.813% | 65.506% |
| iShares S&P 500 | 0.057% | 0.610% | 21.574% | 63.546% |
According to melinda what are the pros and cons of Stratec SE for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Stratec Biomedical AG diskutieren
SecteurEquipement und moderne medizinische Technologie Präsentation Agenda 28/11
STRATEC Biomedical AG, die in der Konstruktion und Herstellung von automatisierten Analysensystemen auf dem Gebiet der klinischen Diagnose und biotechnology.It betreibt durch die folgenden Segmente: Instrumentation, Diatron, Verbrauchsmaterial und alle other.The Instrumentation Segment Bezieht sich auf das Design und
Stopped prediction by melinda for Stratec SE
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
